Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: A potential link between eosinophilia-myalgia syndrome and toxic oil syndrome

Chemical Research in Toxicology

Volumn 20, Issue 10, 2007, Pages 1556-1562

  Martínez Cabot, Anna ^a   Messeguer, Angel ^a  

^a DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPHENOL; ALANINE DERIVATIVE; CARBONYL DERIVATIVE; GLYCINE DERIVATIVE; HYDROGEN; IMINE;

ARTICLE; EOSINOPHILIA MYALGIA SYNDROME; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROLYSIS; INCUBATION TIME; LIVER MICROSOME; MASS SPECTROMETRY; TOXIC OIL SYNDROME;

ALANINE; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE OUTBREAKS; EOSINOPHILIA-MYALGIA SYNDROME; FOOD CONTAMINATION; FOOD POISONING; HUMANS; MICROSOMES, LIVER; PLANT OILS; QUINONES; SPAIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRYPTOPHAN;

TOSCANA VIRUS;

EID: 35848969782     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700256v     Document Type: Article

References (28)

1. Varga, J., Jimenez, S. A., and Uitto, J. (1993) L-Tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis. J. Invest. Dermatol. 100, 457-465.
2. Silver, R. M., Ludwika, A., Hampton, M., Ohba, T., Bingel, S. A., Smith, T., Harley, R. A., Maize, J., and Heyes, M. P. (1994) A murine model of the eosinophilia-myalgia syndrome induced by 1,1′-ethylidenebis (L-tryptophan). J. Clin. Invest. 93, 1473-1480.
3. Hertzman, P. A., Falk, H., Kilbourne, E. M., Page, S., and Shulman, L. E. (1991) The eosinophilia-myalgia syndrome: The Los Alamos Conference. J. Rheumatol. 18, 867-873.
4. Belongia, E. A., Hedberg, C. W., Gleich, G. J., White, K. E., Mayeno, A. N., Loegering, D. A., Dunnette, S. L., Pirie, P. L., McDonald, K. L., and Osterholm, M. T. (1990) An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N. Engl. J. Med. 323, 357-365.
5. Goda, Y., Suzuki, J., Maitani, T., Yoshihira, K., Takeda, M., and Uchiyama, M. (1992) 3-Anilino-L-alanine, structural determination of UV-5, a contaminant in EMS-associated L-tryptophan samples. Chem. Pharm. Bull. 40, 2236-2238.
6. Hill, R. H., Caudill, S. P., Philen, R. M., Bailey, S. L., Flanders, W. D., Driskell, W. J., Kamb, M. L., Needham, L. L., and Sampson, E. J. (1993) Contaminants in L-tryptophan associated with eosinophiliamyalgia syndrome. Arch. Environ. Contam. Toxicol. 25, 134-142.
7. Williamson, B. L., Benson, L. M., Tomlinson, A. J., Mayeno, A. N., Gleich, G. J., and Naylor, S. (1997) On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia myalgia syndrome. Toxicol. Lett. 92, 139-148.
8. Adachi, J., Mio, T., Ueno, Y., Naito, T., Nishimura, A., Fujiwara, S., Sumino, K., and Tatsuno, Y. (1994) Identification of four metabolites of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in rats. Arch. Toxicol. 68, 500-505.
9. Posada de la Paz, M., Philen, R. M., and Abaitua, I. (2001) Toxic oil syndrome: The perspective after twenty years. Epidemiol. Rev. 23, 231-247.
10. World Health Organization. (2004) Toxic Oil Syndrome. Ten Years of Progress, Regional Office for Europe.
11. Mayeno, A. N., Belongia, E. A., Lin, F., Lund, S. K., and Gleich, G. J. (1992) 3-(Phenylamino)alanine, a novel aniline-derived aminoacid associated with eosinophilia-myalgia syndrome: a link to toxic oil syndrome. Mayo Clin. Proc. 67, 1134-1139.
12. Mayeno, A. N., Benson, L. M., Naylor, S., Colberg-Beers, M., Puchalski, J. T., and Gleich, G. J. (1995) Biotransformation of 3-(phenylamino)-1,2- propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome. Chem. Res. Toxicol. 8, 911-916.
13. Ferrer, M., Galceran, M., Sanchez-Baeza, F., Casas, J., and Messeguer, A. (1993) Synthesis of aniline derivatives with potential toxicological implications to the Spanish toxic oil syndrome. Liebigs Ann. Chem., 5, 507-511.
14. Santos de Oliveira, F., Leite, B. C. O., Santana de Andrade, M. V. A., and Korn, M. (2005) Determination of total aldehydes in fuel ethanol by MBTH method-sequential injection analysis. J. Braz. Chem. Soc. 16, 87-92.
15. Martínez-Cabot, A., Morató, A., and Messeguer, A. (2005) Synthesis and stability studies of the glutathione and N-acetylcysteine adducts of an iminoquinone reactive intermediate generated in the biotransformation of 3-(N-phenylamino)propane-1,2-diol: implications for toxic oil syndrome. Chem. Res. Toxicol. 18, 1721-1728.
16. Sai Hang Ho, S., and Zhen Yu, J. (2004) Determination of airborne carbonyls: comparison of a thermal desorption/GC method with the standard DNPH/HPLC method. Environ. Sci. Technol. 38, 862-870.
17. Pappo, D., Vartanian, M., Lang, S., and Kashman, Y. (2005) Synthesis of cyclic endiamino peptides. J. Am. Chem. Soc. 127, 7682-7683.
18. Nakazawa, T., Suzuki, T., and Ishii, M. (1997) Synthesis and characterization of β-O-tosyldehydroserine as a precursor of dehydroamino acids. Tetrahedron Lett. 38, 8951-8954.
19. Cheung, K.-M., and Shoolingin-Jordan, P. M. (1997) Synthesis of 3-amino-3-vinyl propanoic acid and its conversion to 4-amino-5-hydroxy-4,5- dihydrofuran-2-one hydrochloryde (HAD), a cyclic stabilised form of aspartate 1-semialdehyde hydrochloryde. Tetrahedron 53, 15807-15812.
20. Ladona, M. G., Bujons, J., Messeguer, A., Ampurdanés, C., Morató, A., and Corbella, J. (1999) Biotransformation and clearance of 3-(phenylamino)propane-1,2-diol, a compound present in samples related in samples related to toxic oil syndrome, in C57BL/6 and A/J mice. Chem. Res. Toxicol. 12, 1127-1137.
21. Bujons, J., Ladona, M. G., Messeguer, A., Morató, A., and Ampurdanés, C. 2001 Metabolism of (R)- and (S)- 3(phenylamino)propane-1,2-diol in C57BL/6- and A/J-strain mice. Chem. Res. Toxicol. 14, 1097-1106. Identification of new metabolites with toxicological significance to the toxic oil syndrome.
22. Monks, T. J., and Jones, D. C. (2002) The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. Curr. Drug. Metab. 3, 425-438.
23. Sidransky, H., Verney, E., Cosgrove, J. W., and Latham, P. S. (1994) Effect of 3-phenylamino-L-alanine on tryptophan binding to rat hepatic nuclear envelopes. Toxicology 86, 135-145.
24. Klos, C., Koob, M., Kramer, C., and Dekant, W. (1992) p-aminophenol nephrotoxicity: biosynthesis of toxic glutathione conjugates. Toxicol. Appl. Pharmacol. 115, 98-106.
25. Fowler, L. M., Foster, J. R., and Lock, E. A. (1994) Nephrotoxicity of 4-amino-3-S-glutathionylphenol and its modulation by metabolism or transport inhibitors. Arch. Toxicol. 68, 15-23.
26. Lock, E. A., Cross, T. J., and Schnellmann, R. G. (1993) Studies on the mechanism of 4-aminophenol-induced toxicity to renal proximal tubules. Hum. Exp. Toxicol. 12, 383-388.
27. Fu, X., Chen, T. S., Ray, M. B., Nagasawa, H. T., and Williams, W. M. (2004) p-Aminophenol-induced hepatotoxicity in hamsters: role of glutathione. J. Biochem. Mol. Toxicol. 18, 154-161.
28. Yoshida, R., Oikawa, S., Ogawa, Y., Miyakoshi, Y., Ooida, M, Asanuma, K., and Shimizu, H. (1998) Mutagenicity of p-aminophenol in E. coli WP2uvrA/pKM101 and its relevance to oxidative DNA damage. Mutat. Res. 415, 139-150.